In suspected acute coronary syndrome, which measure should be performed if protocol allows?

• A. Administer aspirin if protocol allows and no contraindications
• B. Administer a laxative
• C. Administer a sedative
• D. Begin aggressive IV fluid resuscitation for all

Answer: (A)

In suspected acute coronary syndrome, the priority is to limit platelet aggregation and clot progression to protect heart muscle. Administering aspirin promptly achieves this by irreversibly inhibiting the enzyme in platelets that drives clot formation, which can reduce mortality and improve outcomes when given early. If the protocol allows and there are no contraindications (such as allergy, active GI bleed, or other bleeding risks), give a chewable aspirin dose of about 160–325 mg to the patient so absorption is rapid.

Laxatives have no role in ACS management and can delay treating the actual problem. Sedatives aren’t routinely used and can depress respiration or mask symptoms, potentially delaying critical assessment and treatment. Starting aggressive IV fluids for everyone isn’t appropriate in ACS, as many patients don’t need large-volume resuscitation and it can worsen pulmonary edema or other cardiac conditions; fluids are guided by the patient’s blood pressure, perfusion, and overall status rather than given to all.